drugset / Trial / NCT03106597

Manidipine Versus Amlodipine in Patients With Hypertension

NCT03106597

RandomizedParallel-groupSingle-blindTreatment

Summary

The purpose of this study is to evaluate the effect of a third-generation Calcium Channel Blocker (CCB), manidipine, compared with second-generation Calcium Channel Blocker (CCB), amlodipine, on the development of peripheral edema using Direct Segmental Multi-Frequency Bioelectrical Impedance Analysis (DSM-BIA) method in patients with mild to moderate essential hypertension. Investigator expects this study could show more objective evidence of better safety of manidipine compared with amlodipine for peripheral edema.

Timeline

Start
2015-08-20
Primary completion
2018-05-15
Completion
2019-08-14

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Amlodipine Other / unclassified 10 mg Oral
Subject MANIDIPINE 6300 Small molecule 20 mg Oral